A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
Hoffmann-La Roche
Stanford University
Novartis
TaiHao Medical Inc.
University of Maryland, Baltimore
University of Illinois at Chicago
Envision Healthcare Scientific Intelligence, Inc.
Mayo Clinic
Novartis
University of Kansas Medical Center
Merck Sharp & Dohme LLC